Structures by: Avasthi K.
Total: 32
Cyclophane
C18H20N8O2S2
Organic letters (2009) 11, 22 5290-5293
a=13.075(3)Å b=16.85(1)Å c=9.30(1)Å
α=90.00° β=90.00° γ=90.00°
2-(2-(4,6-bis(methylthio)-1H-pyrazolo[3,4-d]pyrimidin-1-yl) ethyl)phthalazin-1(2H)-one
C17H16N6OS2
CrystEngComm (2012) 14, 2 383
a=16.708(2)Å b=15.732(2)Å c=14.4360(10)Å
α=90.00° β=107.790(10)° γ=90.00°
None
C17H16N6O4S
CrystEngComm (2012) 14, 2 383
a=18.2274(5)Å b=15.2903(4)Å c=13.9319(5)Å
α=90.00° β=108.746(3)° γ=90.00°
None
C17H16N6O4S
CrystEngComm (2012) 14, 2 383
a=9.2490(10)Å b=17.580(2)Å c=11.550(2)Å
α=90.00° β=105.110(10)° γ=90.00°
None
C16H13ClN6O3S
CrystEngComm (2012) 14, 2 383
a=13.6729(8)Å b=9.0043(6)Å c=13.8349(8)Å
α=90.00° β=90.388(5)° γ=90.00°
2-(2-(4-chloro-6-(methylthio)-1H-pyrazolo [3,4-d]pyrimidin-1-yl)ethyl)phthalazin-1(2H)-one
C16H13ClN6OS
CrystEngComm (2012) 14, 2 383
a=9.1610(10)Å b=14.0630(10)Å c=13.1090(10)Å
α=90.00° β=102.120(10)° γ=90.00°
1,3-Bis(2,6-dimethyl sulfanyl-9H-purin-9-yl)-2-methylenyl propane
C18H20N8S4
CrystEngComm (2011) 13, 6 2039
a=16.357(3)Å b=10.062(2)Å c=13.506(3)Å
α=90.00° β=90.00° γ=90.00°
1,3-Bis(4,6-dimethyl sulfanyl-1H-pyrazolo(3,4-d) pyrimidin-1- yl)-2-methylenyl propane
C18H20N8S4
CrystEngComm (2011) 13, 6 2039
a=9.122(5)Å b=9.560(5)Å c=14.181(5)Å
α=102.828(5)° β=102.183(5)° γ=107.820(5)°
1-(9H-carbazol-9-yl)-3-(4-methoxy-6-methylsulfanyl-1H- pyrazolo (3,4-d)pyrimidin-1-yl)-2-methylenepropane
C23H21N5OS
CrystEngComm (2011) 13, 6 2039
a=8.5125(5)Å b=10.6289(7)Å c=11.9705(8)Å
α=70.965(3)° β=81.944(3)° γ=86.356(3)°
1-(9H-carbazol-9-yl)-3-(4,6-dimethylsulfanyl-1H-pyrazolo (3,4- d)pyrimidin-1-yl)-2-methylenepropane
C23H21N5S2
CrystEngComm (2011) 13, 6 2039
a=10.1518(10)Å b=8.7585(9)Å c=24.492(3)Å
α=90.00° β=101.961° γ=90.00°
Pyrazolo[3,4-d]pyrimidine
C18H22N8O2S2
Acta Crystallographica Section E (2002) 58, 8 o940-o941
a=7.4330(10)Å b=8.1170(10)Å c=9.6460(10)Å
α=71.430(10)° β=72.430(10)° γ=71.360(10)°
1,3-bis(8-chlorotheophyllin-7-yl)propane
C17H18Cl2N8O4
Acta Crystallographica Section E (2001) 57, 12 o1163-o1165
a=19.9290(10)Å b=4.3417(2)Å c=22.788(2)Å
α=90.00° β=91.400(10)° γ=90.00°
C13H16N4O4S2
C13H16N4O4S2
Acta Crystallographica Section C (1996) 52, 10 2563-2566
a=7.529(4)Å b=20.689(12)Å c=30.469(16)Å
α=90° β=90° γ=90°
(pyrazolo[3,4-d]pyrimidin-1-yl)alkane
C17H20N8O2S2
Acta Crystallographica Section C (1998) 54, 2 275-277
a=13.459(4)Å b=9.2087(15)Å c=15.883(5)Å
α=90.00° β=98.87(4)° γ=90.00°
C17H20N8S4
C17H20N8S4
Acta Crystallographica Section C (1995) 51, 11 2453-2455
a=9.397(6)Å b=9.627(8)Å c=13.805(8)Å
α=96.20(6)° β=102.31(5)° γ=115.17(6)°
1-[2-(2,6-Dimethylsulfanyl-9<i>H</i>-purin-9-yl)-2-methylidenepropyl]-4,6-bis(methylsulfanyl)-1<i>H</i>-pyrazolo[3,4-<i>d</i>]pyrimidine
C18H20N8S4
Acta Crystallographica Section C (2014) 70, 6 555-561
a=9.285(4)Å b=9.818(4)Å c=13.400(6)Å
α=98.707(7)° β=103.080(3)° γ=109.593(4)°
7,7'-(2-Methylidenepropane-1,3-diyl)bis[3-methyl-2-methylsulfanyl-3<i>H</i>-pyrrolo[2,3-<i>d</i>]pyrimidin-4(7<i>H</i>)-one]
C20H22N6O2S2
Acta Crystallographica Section C (2014) 70, 6 555-561
a=9.859(2)Å b=13.979(4)Å c=29.331(8)Å
α=90.00° β=90.00° γ=90.00°
7-[2-(4,6-Dimethylsulfanyl-1<i>H</i>-pyrazolo[3,4-<i>d</i>]pyrimidin-1-yl)-2-\ methylidenepropyl]-3-methyl-2-methylsulfanyl-3<i>H</i>-pyrrolo[2,3-<i>d</i>]\ pyrimidin-4(7<i>H</i>)-one
C19H21N7OS3
Acta Crystallographica Section C (2014) 70, 6 555-561
a=9.5436(7)Å b=11.5329(8)Å c=21.0042(13)Å
α=90.00° β=107.943(3)° γ=90.00°
Pyrazolo[3,4-d]pyrimidine
C17H20N8S4
Acta Crystallographica Section C (2000) 56, 11 1361-1363
a=7.620(2)Å b=10.411(2)Å c=26.813(5)Å
α=90.00° β=97.92(2)° γ=90.00°
Pyrazolo[3,4-d]pyrimidine
C29H28N8O2S2
Acta Crystallographica Section C (2002) 58, 8 o494-o495
a=9.1500(10)Å b=9.4910(10)Å c=16.839(2)Å
α=83.010(10)° β=85.260(10)° γ=76.390(10)°
Pyrazolo[3,4-d]pyrimidine
C22H29N9S3
Acta Crystallographica Section C (2003) 59, 1 o42-o45
a=10.1195(8)Å b=11.8650(10)Å c=12.2710(10)Å
α=70.563(7)° β=70.092(8)° γ=73.452(7)°
Pyrazolo[3,4-d]pyrimidine
C25H34N10S2
Acta Crystallographica Section C (2003) 59, 1 o42-o45
a=10.0060(10)Å b=15.2830(10)Å c=18.411(2)Å
α=74.164(7)° β=89.970(9)° γ=86.359(9)°
Pyrazolo[3,4-d]pyrimidine
C18H17N5O2S2
Acta Crystallographica Section C (2003) 59, 8 o409-o412
a=10.4710(10)Å b=13.1323(11)Å c=14.0516(12)Å
α=90.00° β=102.190(10)° γ=90.00°
Parazolo[3,4-d]pyrimidine
C21H22N6O2S
Acta Crystallographica Section C (2003) 59, 8 o409-o412
a=7.5993(6)Å b=9.3968(7)Å c=15.376(2)Å
α=80.684(8)° β=82.480(10)° γ=72.685(6)°
Pyrazolo[3,4-d]pyrimidine
C17H20N4OS2
Acta Crystallographica Section C (2003) 59, 9 o494-o495
a=17.9660(10)Å b=10.0890(10)Å c=10.0550(10)Å
α=90.00° β=104.970(10)° γ=90.00°
Pyrazolo[3,4-d]pyrimidine
C25H36N8S4
Acta Crystallographica Section C (2003) 59, 9 o523-o524
a=21.044(2)Å b=8.8140(10)Å c=18.953(2)Å
α=90.00° β=118.070(10)° γ=90.00°
Pyrazolo[3,4-d]pyrimidin
C19H24N8O2S2
Acta Crystallographica Section C (2001) 57, 11 1324-1325
a=31.385(2)Å b=9.1290(10)Å c=16.8400(10)Å
α=90° β=115.52° γ=90°
4-Oxo-4,5-dihydropyrazolo[3,4-d]pyrimidine
C15H16N4OS
Acta Crystallographica Section C (2002) 58, 6 o325-o327
a=9.4742(8)Å b=19.2870(10)Å c=33.032(2)Å
α=90° β=90° γ=90°
Pyrazolo[3,4-d]pyrimidine
C14H14N4O2
Acta Crystallographica Section C (2002) 58, 6 o311-o313
a=7.4760(10)Å b=8.9230(10)Å c=10.1550(10)Å
α=76.680(10)° β=89.080(10)° γ=80.660(10)°
Pyrazolo[3,4-d]pyrimidine
C14H14N4O2
Acta Crystallographica Section C (2002) 58, 6 o311-o313
a=12.4680(10)Å b=7.4490(10)Å c=15.076(2)Å
α=90.00° β=108.940(10)° γ=90.00°
1,3-Bis(9H-carbazol-9-yl)-2-methylenepropane
C28H22N2
CrystEngComm (2011) 13, 6 2039
a=9.3786(17)Å b=23.547(4)Å c=18.543(3)Å
α=90.00° β=90.617(3)° γ=90.00°
Pyrazolo[3,4-d]pyrimidine
C18H22N8O2S2
Acta Crystallographica Section C (2000) 56, 11 1361-1363
a=31.736(7)Å b=8.308(2)Å c=17.467(4)Å
α=90.00° β=115.12(2)° γ=90.00°